G. Ismailos

Correlation between Acinetobacter baumannii Resistance and Hospital Use of Meropenem, Cefepime, and Ciprofloxacin: Time Series Analysis and Dynamic Regression Models

V. Karalis, Rania Kousovista, Christos Athanasiou, 2021, Pathogens.

In Vitro Cytotoxicity of Dry Powder Inhaler Medical Devices

H. Kalofonos, E. Giannopoulou, G. Sivolapenko, 2016 .

Colchicine for the treatment of COVID-19 patients: efficacy, safety, and model informed dosage regimens

V. Karalis, E. Karatza, G. Ismailos, 2021, Xenobiotica; the fate of foreign compounds in biological systems.

Optimization of hydroxychloroquine dosing scheme based on COVID-19 patients’ characteristics: a review of the literature and simulations

V. Karalis, E. Karatza, M. Marangos, 2020, Xenobiotica; the fate of foreign compounds in biological systems.

Bioavailability study of a freeze‐dried sodium phenytoin‐milk formulation

P. Macheras, C. Reppas, G. Ismailos, 1991, Biopharmaceutics & drug disposition.

Unusual solubility behaviour of cyclosporin A in aqueous media

J. Dressman, C. Reppas, P. Macheras, 1991, The Journal of pharmacy and pharmacology.

Chloroquine dosage regimens in patients with COVID-19: Safety risks and optimization using simulations

V. Karalis, E. Karatza, G. Ismailos, 2020, Safety Science.

Clinical and pathophysiological characteristics of valproate-induced pleural effusion

D. Vlachopoulos, Stavros Tryfon, M. Saroglou, 2021, Clinical toxicology.

Modified HPLC analysis of diltiazem in plasma for pharmacokinetic studies

M. Parissi-poulou, P. Macheras, G. Ismailos, 1990 .

Penetration of azithromycin in experimental pleural empyema fluid.

Demosthenes Bouros, A. Papalois, Stavros Tryfon, 2010, European journal of pharmacology.

Enhancement of cyclosporin A solubility by d-alphatocopheryl-polyethylene-glycol-1000 succinate (TPGS)

C. Reppas, P. Macheras, G. Ismailos, 1994 .

Managing the clinical effects of drug-induced intestinal dysbiosis with a focus to antibiotics: challenges and opportunities.

C. Reppas, M. Vertzoni, G. Ismailos, 2023, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.